Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL693122 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL11540653 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL10722450 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL11229618 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL4958852 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL2304845 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL7663036 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL9119248 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL9868874 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 | |
| SCHEMBL1692351 | 1.00 | CES2 (0.52) | CES2FFAR4FFAR1MAPTCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006060759-A2 | A STERICALLY STABILIZED LIPOSOME AND TRIAMCINOLONE COMPOSITION FOR TREATING THE RESPIRATORY TRACT OF A MAMMAL | KONDURI, KAMESWARI, S. (US) | 2006-06-08 | — | — | WO | claimed |
| US-20060115523-A1 | Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal | VGSK TECHNOLOGIES, INC. | 2006-06-01 | — | — | US | claimed |
| WO-1995026722-A1 | METHOD FOR INHIBITING MAST CELL AND BASOPHIL ACTIVATION | CELL THERAPEUTICS, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| WO-2024133635-A1 | COMPOSITION | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2024-06-27 | — | — | WO | disclosed |
| US-20240180835-A1 | STERICALLY STABILIZED CARRIER COMPOSITIONS FOR TREATING A MAMMAL | VGSK TECHNOLOGIES, INC. | 2024-06-06 | — | — | US | disclosed |
| EP-4333809-A1 | LIPOSOME-ENCAPSULATED CORTICOSTERIODS INHIBIT SARS-COV-2 REPLICATION AND REDUCES LUNG INFLAMMATION | VGSK Technologies, Inc. (US) | 2024-03-13 | — | — | EP | disclosed |
| US-20230270756-A1 | LIPOSOMAL FORMULATIONS FOR INHIBITING SARS-CoV-2 REPLICATION AND REDUCING LUNG INFLAMMATION | VGSK TECHNOLOGIES, INC. | 2023-08-31 | — | — | US | disclosed |
| US-20230029342-A1 | STERICALLY STABILIZED CARRIER FOR AEROSOL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING THE RESPIRATORY TRACT OF A MAMMAL | VGSK TECHNOLOGIES, INC. | 2023-01-26 | — | — | US | disclosed |
| US-11324698-B2 | Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal | VGSK TECHNOLOGIES, INC. (US) | 2022-05-10 | — | — | US | disclosed |
| CN-109549927-B | Solid solution compositions and their use in cardiovascular disease | 因佛斯特医疗有限公司 | 2022-03-29 | — | — | CN | disclosed |
| US-20200352859-A1 | Sterically Stabilized Carrier for Aerosol Therapeutics, Compositions and Methods for Treating the Respiratory Tract of a Mammal | VGSK TECH INC (US) | 2020-11-12 | — | — | US | disclosed |
| EP-3349729-A1 | A STERICALLY STABILIZED CARRIER FOR SUBCUTANEOUS, SUBLINGUAL AND ORAL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING A MAMMAL | VGSK Technologies, Inc. (US) | 2018-07-25 | — | — | EP | disclosed |
| WO-2017048860-A1 | A STERICALLY STABILIZED CARRIER FOR SUBCUTANEOUS, SUBLINGUAL AND ORAL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING A MAMMAL | VGSK TECHNOLOGIES, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| US-20150071988-A1 | Sterically Stabilized Carrier For Aerosol Therapeutics, Compositions And Methods For Treating The Respiratory Tract Of A Mammal | VGSK TECHNOLOGIES, INC. | 2015-03-12 | — | — | US | disclosed |
| US-8846079-B1 | Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal | VGSK TECHNOLOGIES, INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-20060251711-A1 | Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating diseases of the respiratory tract of a mammal | VGSK TECHNOLOGIES, INC. | 2006-11-09 | — | — | US | disclosed |
| WO-2006060759-A2 | A STERICALLY STABILIZED LIPOSOME AND TRIAMCINOLONE COMPOSITION FOR TREATING THE RESPIRATORY TRACT OF A MAMMAL | KONDURI, KAMESWARI, S. (US) | 2006-06-08 | — | — | WO | disclosed |
| US-20060115523-A1 | Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal | VGSK TECHNOLOGIES, INC. | 2006-06-01 | — | — | US | disclosed |
| WO-2004037270-A1 | CYCLOOXYGENASE REGULATION WITH PG LIPOSOMES | VASOGEN IRELAND LIMITED (IE) | 2004-05-06 | — | — | WO | disclosed |
| WO-1995026722-A1 | METHOD FOR INHIBITING MAST CELL AND BASOPHIL ACTIVATION | CELL THERAPEUTICS, INC. (US) | 1995-10-12 | — | — | WO | disclosed |